Furthermore, compared with OMT or DDP alone treatment, co-treatment OMT with DDP significantly increased the CD8+/Treg ratio in PBMCs, spleen lymphocytes and tumor infiltrating lymphocytes (Figure 3D). The gene discussed is CD8A; the disease is neoplasm.